Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

Sarcoma
Volume 2012 (2012), Article ID 475202, 9 pages
http://dx.doi.org/10.1155/2012/475202
Clinical Study

Desmoid Fibromatosis in Pediatric Patients: Management Based on a Retrospective Analysis of 59 Patients and a Review of the Literature

1Pediatric Oncology Department, Hôpital de la mère et de l'enfant, 8 rue Dominique Larrey, 87042 Limoges, France
2Adolescent and Pediatric Oncology Department, Institut Curie, 75005 Paris, France
3Pediatric Department, Institut Gustave Roussy, 94800 Villejuif, France
4Pediatric Surgery Department, Hôpital Trousseau, 75012 Paris, France
5Pediatric Surgery Department, Hôpital Necker-Enfants-Malades, 75012 Paris, France
6Radiotherapy Department, Institut Curie, 75005 Paris, France
7Radiotherapy Department, Centre Hospitalier Universitaire de Caen, 14000 Caen, France

Received 29 February 2012; Revised 14 May 2012; Accepted 14 June 2012

Academic Editor: C. Fisher

Copyright © 2012 Caroline Oudot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. Kingston, C. M. Owens, A. Jeanes, and M. Malone, “Imaging of desmoid fibromatosis in pediatric patients,” American Journal of Roentgenology, vol. 178, no. 1, pp. 191–199, 2002. View at Google Scholar · View at Scopus
  2. C. Wu, S. Nik-Amini, P. Nadesan, W. L. Stanford, and B. A. Alman, “Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells,” Cancer Research, vol. 70, no. 19, pp. 7690–7698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Meazza, G. Bisogno, A. Gronchi et al., “Aggressive fibromatosis in children and adolescents: the Italian experience,” Cancer, vol. 116, no. 1, pp. 233–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Giarola, D. Wells, P. Mondini et al., “Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours,” British Journal of Cancer, vol. 78, no. 5, pp. 582–587, 1998. View at Google Scholar · View at Scopus
  5. H. Lackner, C. Urban, R. Kerbl, W. Schwinger, and A. Beham, “Noncytotoxic drug therapy in children with unresectable desmoid tumors,” Cancer, vol. 80, no. 2, pp. 334–340, 1997. View at Google Scholar
  6. B. A. Guadagnolo, G. K. Zagars, and M. T. Ballo, “Long-term outcomes for desmoid tumors treated with radiation therapy,” International Journal of Radiation Oncology Biology Physics, vol. 71, no. 2, pp. 441–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Jabbari, D. Andolino, V. Weinberg et al., “Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 1, pp. 177–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Rutenberg, D. J. Indelicato, J. A. Knapik et al., “External-beam radiotherapy for pediatric and young adult desmoid tumors,” Pediatric Blood and Cancer, vol. 57, no. 3, pp. 435–442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Buitendijk, C. P. van de Ven, T. G. Dumans et al., “Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of the literature,” Cancer, vol. 104, no. 5, pp. 1090–1099, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. X. Skapek, W. S. Ferguson, L. Granowetter et al., “Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group phase II trial,” Journal of Clinical Oncology, vol. 25, no. 5, pp. 501–506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. B. Faulkner, S. I. Hajdu, U. Kher et al., “Pediatric desmoid tumor: retrospective analysis of 63 cases,” Journal of Clinical Oncology, vol. 13, no. 11, pp. 2813–2818, 1995. View at Google Scholar · View at Scopus
  12. T. E. Merchant, D. Nguyen, A. W. Walter, A. S. Pappo, L. E. Kun, and B. N. Rao, “Long-term results with radiation therapy for pediatric desmoid tumors,” International Journal of Radiation Oncology Biology Physics, vol. 47, no. 5, pp. 1267–1271, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Bonvalot, H. Eldweny, V. Haddad et al., “Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients,” European Journal of Surgical Oncology, vol. 34, no. 4, pp. 462–468, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Fiore, F. Rimareix, L. Mariani et al., “Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment,” Annals of Surgical Oncology, vol. 16, no. 9, pp. 2587–2593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Bocale, M. T. Rotelli, A. Cavallini, and D. F. Altomare, “Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review,” Colorectal Disease, vol. 13, no. 12, pp. e388–e395, 2011. View at Publisher · View at Google Scholar
  16. P. Therasse, S. G. Arbuck, E. A. Eisenhauer et al., “New guidelines to evaluate the response to treatment in solid tumors,” Journal of the National Cancer Institute, vol. 92, no. 3, pp. 205–216, 2000. View at Google Scholar · View at Scopus
  17. S. S. Donaldson, G. J. Draper, and F. Flamant, “Topography of childhood tumors: pediatric coding system,” Pediatric Hematology and Oncology, vol. 3, no. 3, pp. 249–258, 1986. View at Google Scholar · View at Scopus
  18. L. H. Sobin and C. C. Compton, “TNM seventh edition: what's new, what's changed: communication from the International Union against Cancer and the American Joint Committee on Cancer,” Cancer, vol. 116, no. 22, pp. 5336–5339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Lawrence Jr., J. R. Anderson, E. A. Gehan, and H. Maurer, “Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group,” Cancer, vol. 80, no. 6, pp. 1165–1170, 1997. View at Google Scholar
  20. E. L. kaplan and P. Meier, “Non parametric estimation from incomplete observation,” The American Statistical Association, vol. 53, pp. 457–481, 1958. View at Google Scholar
  21. J. P. Dormans, D. Spiegel, J. Meyer et al., “Overview plus: fibromatoses in childhood: the desmoid/fibromatosis complex,” Medical and Pediatric Oncology, vol. 37, no. 2, pp. 126–131, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Reitamo, T. M. Scheinin, and P. Hayry, “The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor,” American Journal of Surgery, vol. 151, no. 2, pp. 230–237, 1986. View at Google Scholar · View at Scopus
  23. M. T. Ballo, G. K. Zagars, A. Pollack, P. W. T. Pisters, and R. A. Pollock, “Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy,” Journal of Clinical Oncology, vol. 17, no. 1, pp. 158–167, 1999. View at Google Scholar · View at Scopus
  24. M. A. Spear, L. C. Jennings, H. J. Mankin et al., “Individualizing management of aggressive fibromatoses,” International Journal of Radiation Oncology Biology Physics, vol. 40, no. 3, pp. 637–645, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Salas, A. Dufresne, B. Bui, J. Y. Blay, P. Terrier, D. Ranchere-Vince et al., “Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation,” Journal of Clinical Oncology, vol. 29, no. 26, pp. 3553–3558, 2011. View at Google Scholar
  26. M. Alebouyeh, F. Moussavi, A. K. N. Tabari, and P. Vossough, “Aggressive intra-abdominal fibromatosis in children and response to chemotherapy,” Pediatric Hematology and Oncology, vol. 22, no. 6, pp. 447–451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Azzarelli, A. Gronchi, R. Bertulli, J. D. Tesoro, D. Baratti, E. Pennacchioli et al., “Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis,” Cancer, vol. 92, no. 5, pp. 1259–1264, 2001. View at Google Scholar
  28. S. H. Okuno and J. H. Edmonson, “Combination chemotherapy for desmoid tumors,” Cancer, vol. 97, no. 4, pp. 1134–1135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Mace, J. Sybil Biermann, V. Sondak et al., “Response of extraabdominal desmoid tumors to therapy with imatinib mesylate,” Cancer, vol. 95, no. 11, pp. 2373–2379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Meazza, M. Casanova, G. Trecate, and A. Ferrari, “Objective response to hydroxyurea in a patient with heavily pre-treated aggressive fibromatosis,” Pediatric Blood and Cancer, vol. 55, no. 3, pp. 587–588, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Meazza, G. Bisogno, M. Casanova, I. Zanetti, M. Carli, and A. Ferrari, “Full-dose ifosfamide can be safely administered to outpatients,” Pediatric Blood and Cancer, vol. 50, no. 2, pp. 375–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. A. J. F. Lazar, D. Tuvin, S. Hajibashi et al., “Specific mutations in the β-Catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors,” American Journal of Pathology, vol. 173, no. 5, pp. 1518–1527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Gebert, J. Hardes, C. Kersting et al., “Expression of β-catenin and p53 are prognostic factors in deep aggressive fibromatosis,” Histopathology, vol. 50, no. 4, pp. 491–497, 2007. View at Publisher · View at Google Scholar · View at Scopus